Involvement of Nucleic Acid Synthesis in Cell Killing Mechanisms of Topoisomerase Poisons

Cancer Research

Volumn 50, Issue 21, 1990, Pages 6919-6924

  D'Arpa, Peter ^a   Beardmore, Christopher ^a   Liu, Leroy F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; APHIDICOLIN; CAMPTOTHECIN; CORDYCEPIN; CYCLOHEXIMIDE; DNA TOPOISOMERASE; ETOPOSIDE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE PHASE; CELL STRAIN V 79; DRUG CYTOTOXICITY; HAMSTER; NONHUMAN; NUCLEIC ACID SYNTHESIS; PRIORITY JOURNAL;

AMSACRINE; ANIMAL; ANTIBIOTICS, ANTINEOPLASTIC; APHIDICOLIN; CAMPTOTHECIN; CELL SURVIVAL; CRICETULUS; CYCLOHEXIMIDE; DEOXYADENOSINES; DICHLORORIBOFURANOSYLBENZIMIDAZOLE; DITERPENES; DNA; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; ETOPOSIDE; HAMSTERS; MUTAGENS; NUCLEIC ACIDS; RNA; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0025133118     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Liu, L. F. DNA topoisomerase poisons as antitumor drugs. Ann. Rev. Biochem., 58: 351–375, 1989.
2. D'Arpa, P., and Liu, L. F. Topoisomerase-targeting antitumor drugs. Biochim. Biophys. Acta, 989: 163–177, 1989.
3. Tewey, K. M., Chen, G. L., Nelson, E. M., and Liu, L. F. Intercalate antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J. Biol. Chem., 259: 9182–9187, 1984.
4. Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. C., and Liu, L. F. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science (Washington, DC), 226:466–468, 1984.
5. Nelson, E. M., Tewey, K. M., and Liu, L. F. Mechanism of antitumor drugs. Poisoning of mammalian DNA topoisomerase II on DNA by an antitumor drug m-AMSA. Proc. Natl. Acad. Sci. USA, 81:1361–1365, 1984.
6. Long, B. H., Musial, S. T., and Brattain, M. G. Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16–213 and VM26: a quantitative structure-activity relationship. Biochemistry, 25:1183–1188, 1984.
7. Pommier, Y., Mattern, M. R., Schwartz, R. E., Zwelling, L. A., and Kohn, K. W. Changes in deoxyribonucleic acid linking number due to treatment of mammalian cells with the intercalating agent 4′-(9-acridinylamino) methanesulfon-m-anisidide. Biochemistry, 23: 2927–2932, 1984.
8. Hsiang, Y-H., and Liu, L. F. Evidence for the reversibility of cellular DNA lesion induced by mammalian topoisomerase II poisons. J. Biol. Chem., 264: 9713–9715, 1989.
9. Hsiang, Y-H, Lihou, M. G., and Liu, L. F. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res., 49: 5077–5082, 1989.
10. Rowe, T. C., Chen, G. L., Hsiang, Y-H., and Liu, L. F. DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II. Cancer Res., 46: 2021–2026, 1986.
11. Li, L. H., Fraser, T. J., Olin, E. J., and Bhuyan, B. K. Action of camptothecin on mammalian cells in culture. Cancer Res., 32: 2643–2650, 1972.
12. Holm, C., Covey, J. M., Kerrigan, D., and Pommier, Y. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and topoisomerase II inhibitors in Chinese hamster DC3F cells. Cancer Res., 49: 6365–6368, 1989.
13. Horwitz, S. B., and Horwitz, M. S. Effects of camptothecin on the breakage and repair of DNA during the cell cycle. Cancer Res., 33: 2834–2836, 1973.
14. Vindelov, L. L. Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. Virchows Arch. B Cell Pathol., 24: 227–242, 1977.
15. Wilson, W. R., and Whitmore, G. F. Cell-cycle-stage specificity of 4′-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and interaction with ionizing radiation in mammalian cell cultures. Radiat. Res., 87: 121–136, 1981.
16. Schneider, E., Lawson, P. A., and Ralph, R. K. Inhibition of protein synthesis reduces the cytotoxicity of 4′-(9-acridinylamino)methanesulfon-m-anisidide without affecting DNA breakage and DNA topoisomerase II in a murine mastocytoma cell line. Biochem. Pharmacol., 38: 2–25, 1989.
17. Chow, K. C., King, C. K., and Ross, W. E. Abrogation of etoposide-mediated cytotoxicity by cycloheximide. Biochem. Pharmacol., 37: 1117–1122, 1988.
18. Zhang, H., Wang, J. C., and Liu, L. F. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proc. Natl. Acad. Sci. USA, 85: 1060–1064, 1988.
19. Maale, G., Stein, G., and Mans, R. Effects of cordycepin and cordycepintriphosphate on polyadenylic and ribonucleic acid-synthesizing enzymes from eukaryotes. Nature (Lond.), 255: 80–82, 1975.
20. Tamm, I., Hand, R., and Caliguri, L. A. Action of dichlorobenzimidazole riboside on RNA synthesis in L-929 and HeLa cells. J. Cell Biol., 69: 229–240, 1976.
21. Kjeldson, E., Bonven, B. J., Andoh, T., Okada, K., Bolund, L., and Westergaard, O. Characterization of a camptothecin resistant human DNA topoisomerase I. J. Biol. Chem., 263: 3912–3916, 1988.
22. Nitiss, J., and Wang, J. C. DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc. Natl. Acad. Sci. USA, 85: 7501–7505, 1988.
23. Eng, W-K., Faucette, L., Johnson, R. K., and Sternglanz, R. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. Mol. Pharmacol., 34: 755–760, 1989.
24. Li, G. C. Heat shock proteins: role in thermotolerance, drug resistance, and relationship to DNA topoisomerase. Natl. Cancer Inst. Monogr., 4:99–103, 1987.
25. Champoux, J. J. Topoisomerase I is preferentially associated with isolated replicating simian virus 40 molecules after treatment of infected cells with camptothecin. J. Virol., 62: 3675–3683, 1988.
26. Avemann, K., Knippers, R., Roller, T., and Sogo, J. M. Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks. Mol. Cell. Biol., 8: 3026–3034, 1988.
27. Estey, L., Adlakha, R. C., Hittelman, W. N., and Zwelling, L. A. Cell cycle stage dependent variations in drug-induced topoisomerase II mediated DNA cleavage and cytotoxicity. Biochemistry, 26:4338–4344, 1987.
28. Markovits, J., Pommier, Y., Kerrigan, D., Covey, J. M., Tilchen, E. J., and Kohn, K. W. Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells. Cancer Res., 47: 2050–2055, 1987.
29. Long, B. H., Musial, S. T., and Brattain, M. G. Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide. Cancer Res., 45: 3106–3112, 1985.
30. Long, B. H., Musial, S. T., and Brattain, M. G. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide. Cancer Res., 46: 3809–3816, 1986.
31. Charcosset, J-Y., Bendirdjian, J-P., Lantieri, M-F., and Jacquemin-Sablon, A. Effects of 9-OH-ellipticine on cell survival, macromolecular syntheses, and cell cycle progression in sensitive and resistant Chinese hamster lung cells. Cancer Res., 45: 4229–4236, 1985.
32. Yang, L., Rowe, T. C., Nelson, E. M., and Liu, L. F. In vivo mapping of DNA topoisomerase H-specific cleavage sites on SV40 chromatin. Cell, 41: 127–132, 1985.
33. Rowe, T. C., Wang, J. C., and Liu, L. F. In vivo localization of DNA topoisomerase II cleavage sites on Drosophila heat-shock chromatin. Mol. Cell. Biol., 6: 985–992, 1986.